Caplight Directory>Investors>Esperante Ventures>Esperante-ventures


Esperante Ventures

Esperante Ventures

Hoofddorp, North Hollandesperanteventures.com

Overview

Esperante Ventures is a corporate venture capital firm affiliated with a global life science group, boasting leadership with deep operational expertise in the development, manufacturing, and global marketing of prescription pharmaceuticals and in vitro clinical diagnostic tests . Since its establishment in 2004, Esperante has strategically invested in pharmaceutical and diagnostic companies across the US, UK, continental Europe, and Israel . The firm focuses on initial investments of up to EUR 2,000,000 per venture in collaboration with other investors, aiming for exits through sales or liquidity events within a three-year timeframe .

Year Founded

2004

Portfolio Companies

4

Investments

CompanyDateStageLead
Acousia Therapeutics GmbHJan 2024VC RoundCo-investor
Spiral TherapeuticsAug 2023VC RoundLead
PneumagenJun 2023Early FundingCo-investor
View all investments

Sector & Stage Mix

Industry, funding stage, and valuation band breakdowns.

Premium
SeedSeries ASeries BGrowth

Unlock portfolio analytics

Sign up to view full sector, stage, and valuation breakdowns for this investor.

Investment Activity

Yearly cadence, pace, and funding raised over time.

Premium
2021
2022
2023
2024
2025
2026

Unlock portfolio analytics

Sign up to explore yearly investment trends and funding raised over time.

FAQ

Firmographic Details

HeadquartersHoofddorp, North Holland
Year Founded2004

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.





Caplight Logo




Use CasesInvestorsEmployees

CompaniesAll Companies

LegalPrivacy PolicyTerms of UseBrokerCheckForm CRS


Disclaimer All investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.